الفهرس | Only 14 pages are availabe for public view |
Abstract LUTS caused by BPH frequently affect older men, with a prevalence exceeding 50% among males aged 50 and above. Conventional TURP remains the gold standard treatment for symptomatic BPH. Nonetheless, post-TURP morbidity, notably with monopolar TURP, continues to pose challenges, including higher rates of transfusion due to bleeding (0.4% to 6.4%) and delayed postoperative bleeding (1.3% to 1.7%). Bipolar electrosurgical technology has gained global recognition, with multiple companies introducing devices designed to reduce the side effects associated with monopolar TURP, all while preserving effectiveness and long-term outcomes. The integration of lasers in BPH treatment has posed a challenge to TURP, driven by advancements in laser technology, better understanding of tissue–laser interactions, and technical improvements. HoLEP is a recent technology introduced as a line of management of BPH. It stands as a dependable and effective surgical technique, delivering outcomes like TURP and OP but with reduced complications and shorter hospital stays. Additionally, the enhancements in outcome measures endure over time, with minimal long-term complications and reoperation rates. It is size independent procedure adopting the same surgical principle of OP. HoLEP offers an alternative endoscopic treatment that involves minimal blood loss, reduced catheterization time, and shorter hospital stays compared to other endoscopic treatments. In the current decade, the top-down technique for performing HoLEP has been recently developed and described by Nadia et al. since 2017 in Indiana University, USA. |